Obsessive Compulsive Disorder - Phoenix AZ

Clinical Trial 48451

Phoenix, AZ 85012

Summary:

Randomized, double-blinded, placebo controlled trial of adjunctive troriluzole in Obsessive compulsive disorder

Qualified Participants Must:

• Diagnosis of obsessive compulsive disorder for 1 yr
• Be on treatment for OCD for 8 weeks
• 18-65 years old
• No diagnosis of bipolar

Qualified Participants May Receive:

compensation for time and travel

transporation available for all patients

Available At:

Alea Research
3030 N. Central Ave ste 607
Phoenix, AZ 85012
View Clinic Location

 

If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.



© 1998-2024 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides information on clinical trials and other research opportunities worldwide.

ClinicalConnection.com does not conduct or endorse this research. Please consult your physician before participating.

Latest Blog Posts

Useful Links

Contact Us

75 Second Ave, Suite 605
Needham, MA 02494
1-800-887-0639
info@clinicalconnection.com
Click here to contact us

1998-2024 © All Rights Reserved. Privacy Policy | Terms of Service